Mark G Saifer

Title: Mark G Saifer: Innovator in Polymer Conjugates

Introduction

Mark G Saifer is a notable inventor based in the United States. He has made significant contributions to the field of polymer conjugates, particularly in reducing antigenicity and immunogenicity in bioactive components. His work has implications for both diagnostic and therapeutic applications.

Latest Patents

Mark G Saifer holds patents related to innovative methods for preparing conjugates of bioactive components with water-soluble polymers. One of his latest patents is titled "Polymer Conjugates With Decreased Antigenicity, Methods Of Preparation And Uses Thereof." This invention provides methods for creating conjugates that exhibit reduced antigenicity compared to traditional methods. Another significant patent is "Peg-Urate Oxidase Conjugates And Use Thereof," which involves covalently coupling urate oxidase to poly(ethylene glycol) to create non-immunogenic conjugates that retain substantial enzymatic activity.

Career Highlights

Throughout his career, Mark G Saifer has worked with various organizations, including Mountain View Pharmaceuticals, Inc. and Duke University. His experience in these institutions has allowed him to advance his research and contribute to the field of biochemistry.

Collaborations

Mark has collaborated with notable colleagues, including Alexa L Martinez and Merry R Sherman. These partnerships have likely enriched his research and expanded the impact of his inventions.

Conclusion

Mark G Saifer is a distinguished inventor whose work in polymer conjugates has the potential to transform therapeutic and diagnostic practices. His innovative approaches continue to pave the way for advancements in the field.